CRISPR/Cas9 genome editing is used to introduce a c.1343 C-to T point mutation (p.Pro448Leu, P448L), and an additional nucleotide change encoding a silent mutation (P451P, CCC to CCA). The mutation is associated with severe congenital muscular dystrophy (CMD). (J:101977)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count